Anesthesiology pp 155-171 | Cite as

Anesthesia Issues in Patients with VADs Presenting for Noncardiac Surgery

  • Ahmed AwadEmail author
  • Alann Solina
  • Theresa Gerges
  • Muhammad Muntazar


You are the anesthesiologist on call; it is around midnight, and things are winding down. You thought you could go to your on-call room and relax. Minutes later, you receive a call from surgeon Dr. Smith telling you he is booking a patient for an open appendectomy. You think that shouldn’t be that bad. He adds this patient is being transferred from another hospital and, by the way, the patient has a device. You ask what type of device? He replies one of these devices! Oh yeah ..a ventricular assist device! Then he asks how soon can we go to the operating room and start. Now you wonder what should you do? Should you call the cardiac anesthesiologist? Do we need a cardiac surgeon? What if the device malfunctions? Then what? What are the important considerations and preoperative evaluation for a patient with a ventricular assist device? What should you use for anesthetic agents, and what kinds of techniques are appropriate? If the patient is anticoagulated, do we need to reverse the anticoagulation for surgery? Is antibiotic coverage necessary, and what kind of drugs should we use? If the patient develops cardiac arrest, can we do chest compressions? One needs to have a plan and management strategy to address these questions before proceeding to surgery. Anesthesiologists should be acquainted with the unique issues associated with these patients and their mechanically assisted devices. As it is crucial for noncardiac anesthesiologists to familiarize themselves with the management of these patients, we have put together a roadmap that provides a stepwise approach to managing such challenging patients. This chapter highlights the most important points for the noncardiac anesthesiologist to consider when caring for patients with a ventricular assist device including the important features of the commonly used devices, the major perioperative considerations, and the anesthetic management.


Mechanical circulatory support Ventricular assist device VAD Heartmate Heartware Heart failure INTERMACS Noncardiac surgery Perioperative management 


  1. 1.
    Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2009;119:e391–479.CrossRefPubMedGoogle Scholar
  2. 2.
    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M. Heart disease and stroke statistics—2016 update. Circulation. 2016;133:e38–e360.CrossRefPubMedGoogle Scholar
  3. 3.
    Rose EA, Gelljns AC, Moskowrtz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assit device for end-stage heart failure. N Engl J Med. 2001;345(20):1435–43.CrossRefPubMedGoogle Scholar
  4. 4.
    Rogers JG, Butler J, Lansman SL, Gass A, Portner PM, Pasque MK, et al. Chronic mechanical circulatory support for inotrope-dependent heart failure patients who are not transplant candidates: results of the INTrEPID trial. J Am Coll Cardiol. 2007;50(8):741–7.CrossRefPubMedGoogle Scholar
  5. 5.
  6. 6.
    Park SJ, Milano CA, Tatooles AJ, Rogers JG, Adamson RM, et al. Outcomes in advanced heart failure patients with left ventricular assist devices for destination therapy. Circ Heart Fail. 2012;5:241–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Kirklin JK, et al. Seventh INTERMACS annual report: 15,000 patients and counting. J Heart Lung Transplant. 2015;34(12):1495–504.CrossRefPubMedGoogle Scholar
  8. 8.
    Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant. 2009;28:535–41.CrossRefPubMedGoogle Scholar
  9. 9.
    Slininger KA, Haddadin AS, Mangi AA. Perioperative management of patients with left ventricular assist devices undergoing noncardiac surgery. J Cardiothorac Vasc Anesth. 2013;27(4):752–9.CrossRefPubMedGoogle Scholar
  10. 10.
    Estep JD, Starling RC, Horstmanshof DA, Milano CA, Selzman CH, Shah KB, Loebe M, Moazami N, Long JW, Stehlik J, et al. Risk assessment and comparative effectiveness of left ventricular assist device and medical management in ambulatory heart failure patients: results from the ROADMAP study. J Am Coll Cardiol. 2015;66(16):1747–61.CrossRefPubMedGoogle Scholar
  11. 11.
    Mehra MR, Naka Y, Uriel N, Goldstein DJ, Rogers JC, Slaughter MS, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376:451–60.CrossRefGoogle Scholar
  12. 12.
    Rogers JG, Pagani FD, Antone J, Mehra MR, Naka Y, Uriel N, Goldstein DJ, Cleveland JC Jr, Colombo PC, Walsh MN, Salerno C, et al. Intrapericardial left ventricular assist device for advanced heart failure. N Engl J Med. 2017;376(5):440–50.CrossRefGoogle Scholar
  13. 13.
    Hasin T, Topilsky Y, Schirger JA, et al. Changes in renal function after implantation of continuous-flow left ventricular assist devices. J Am Coll Cardiol. 2012;59(1):26–36.CrossRefPubMedGoogle Scholar
  14. 14.
    Schaffer JM, Arnaoutakis GJ, Allen JG, Weiss ES, Patel ND, Russell SD, Shah AS, Conte JV. Bleeding complications and blood product utilization with left ventricular assist device implantation. Ann Thorac Surg. 2011;91(3):740–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Eckman PM, John R. Bleeding and thrombosis in patients with continuous-flow ventricular assist devices. Circulation. 2012;125(24):3038–47.CrossRefPubMedGoogle Scholar
  16. 16.
    Gordon RJ, Quagliarello B, Lowy FD. Ventricular assist device-related infections. Lancet Infect Dis. 2006;6(7):426–37.CrossRefPubMedGoogle Scholar
  17. 17.
    Topkara VK, Kondareddy S, Malik F, Wang IW, Mann DL, Ewald GA, et al. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era. Ann Thorac Surg. 2010;90(4):1270–7.CrossRefPubMedGoogle Scholar
  18. 18.
    Katugaha SB, Gibreal M, Carter AC, Cowger JA, Salerno CT, Maltais S, Dunlay S, Dardas TF, Aaronson KD, Pagani FD, Stulak J, Shah P. The effect of infections in VAD recipients on survival and risk of thromboembolism. J Heart Lung Transplant. 2017;36(4):S38.CrossRefGoogle Scholar
  19. 19.
    Anderson M, Videbaek R, Boesgaard S, et al. Incidence of ventricular arrhythmias in patients on long term support with a continuous-flow assist device (HeartMate II). J Heart Lung Transplant. 2009;28:733–5.CrossRefGoogle Scholar
  20. 20.
    Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomesJ. Thorac Cardiovasc Surg. 2010;139(5):1316–24.CrossRefGoogle Scholar
  21. 21.
    Vollkron M, Voitl P, Ta J, Wieselthaler G, Schima H. Suction events during left ventricular support and ventricular arrhythmias. Anesth Analg. 2007;26(8):819–25.Google Scholar
  22. 22.
    John R, Mantz K, Eckman P, Rose A, May-Newman K. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant. 2010;29(12):1321–9.CrossRefPubMedGoogle Scholar
  23. 23.
    Slaughter MS, Pagani FD, Rogers JG, et al. Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. J Heart Lung Transplant. 2010;29(4):S1–39.CrossRefPubMedGoogle Scholar
  24. 24.
    Rajagopal K, Daneshmand MA, Patel CB, Ganapathi AM, Schechter MA, Rogers JG, Milano CA. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation. J Thorac Cardiovasc Surg. 2013;145(5):1373–9.CrossRefPubMedGoogle Scholar
  25. 25.
    Malehsa D, Meyer AL, Bara C, Struber M. Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. Eur J Cardiothorac Surg. 2009;35(6):1091–3.CrossRefPubMedGoogle Scholar
  26. 26.
    Starling RC, Moazami N, Silvestry SC, Ewald G, Rogers JG, Milano CA, et al. Unexpected abrupt increase in left ventricular assist device thrombosis. N Engl J Med. 2014;370(1):33–40.CrossRefPubMedGoogle Scholar
  27. 27.
    Riha H, Netuka I, Kotulak T, et al. Anesthesia management of a patient with a ventricular assist device for noncardiac surgery. Semin Cardiothorac Vasc Anesth. 2010;14(1):29–31.CrossRefPubMedGoogle Scholar
  28. 28.
    Stone ME. Current status of mechanical circulatory assistance. Semin Cardiothorac Vasc Anesth. 2007;11:185–204.CrossRefPubMedGoogle Scholar
  29. 29.
    Sheu R, Joshi B, High K, Thinh Pham D, Ferreira R, Cobey F. Perioperative management of patients with left ventricular assist devices undergoing noncardiac procedures: a survey of current practices. J Cardiothorac Vasc Anesth. 2015;29:17–26.CrossRefPubMedGoogle Scholar
  30. 30.
    Stone M, Hinchey J, Sattler C, Evans A. Trends in the management of patients with left ventricular assist devices presenting for noncardiac surgery: a 10-year institutional experience. Semin Cardiothorac Vasc Anesth. 2016;20:197–204.CrossRefPubMedGoogle Scholar
  31. 31.
    Hessel EA 2nd. Management of patients with implanted ventricular assist devices for noncardiac surgery: a clinical review. Semin Cardiothorac Vasc Anesth. 2014;18:57–70.CrossRefPubMedGoogle Scholar
  32. 32.
    Goudra BG, Singh PM. Anaesthesia for gastro intestinal endoscopy inpatients with left ventricular assist devices: initial experience with 68 procedures. Ann Card Anaesth. 2013;16:250–6.CrossRefPubMedGoogle Scholar
  33. 33.
    Myers TJ, Bolmers M, Gregoric ID, Kar B, Frazier OH. Assessment of arterial blood pressure during support with an axial flow left ventricular assist device. J Heart Lung Transplant. 2009;28(5):423–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Oleyar M, Stone M, Neustein SM. Perioperative management of a patient with a nonpulsatile left ventricular-assist device presenting for noncardiac surgery. J Cardiothorac Vasc Anesth. 2010;24(5):820–3.CrossRefPubMedGoogle Scholar
  35. 35.
    Morgan JA, Paone G, Nemeh HW, Murthy R, Williams CT, Lanfear DE, Tita C, Brewer RJ. Impact of continuous-flow left ventricular assist device support on right ventricular function. J Heart Lung Transplant. 2013;32(4):398–403.CrossRefPubMedGoogle Scholar
  36. 36.
    Chung M, Sobol J, Sladen R. Ventricular assist device classification and basic functional mechanics. In: High K, editor. Mechanical circulatory support: ventricular assist devices (VADs) and extracorporeal membrane oxygenation (ECMO); 2014.Google Scholar
  37. 37.
    Ozmete O, Bali C, Ergenoglu P, Suner HI, Aribogan A. Resuscitation experience in a patient with left ventricular assist device. J Clin Anesth. 2016;34:253–4.9.CrossRefPubMedGoogle Scholar
  38. 38.
    Nelson EW, Hdnke T, Finley A, et al. Management of LVAD patients for noncardiac surgery: a single-institution study. J Cardiothorac Vasc Anesth. 2015;29(4):898–900.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Ahmed Awad
    • 1
    Email author
  • Alann Solina
    • 2
  • Theresa Gerges
    • 3
  • Muhammad Muntazar
    • 4
  1. 1.Cardiac AnesthesiologyCooper Medical School of Rowan University/Cooper University Health CareCamdenUSA
  2. 2.Department of AnesthesiologyCooper Medical School of Rowan University/Cooper University Health CareCamdenUSA
  3. 3.Cooper Medical School of Rowan University/Cooper University Health CareCamdenUSA
  4. 4.Cardiac AnesthesiologyDeborah Heart and Lung CenterBrowns MillsUSA

Personalised recommendations